2016 European Guidelines on cardiovascular disease prevention in clinical practice
Европейские рекомендации 2016 года по профилактике сердечно-сосудистых заболеваний в клинической практике
2016-05-23
SCID: 54.1/fd3qstfm
Discuss with AI
ESC GuidelinesEuropean Guidelinescardiovascular disease preventionclinical practice
Figures from the paper
Abstract (AI)
Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the population level or targeted at an individual, that are aimed at eliminating or minimizing the impact of CVDs and their related disabilities.1 CVD remains a leading cause of morbidity and mortality, despite improvements in outcomes. Age-adjusted coronary artery disease (CAD) mortality has declined since the 1980s, particularly in high-income regions.2 CAD rates are now less than half what they were in the early 1980s in many countries in Europe, due to preventive measures including the success of smoking legislation. However, inequalities between countries persist and many risk factors, particularly obesity3 and diabetes mellitus (DM),4 have been increasing substantially. If prevention was practised as instructed it would markedly reduce the prevalence of CVD. It is thus not only prevailing risk factors that are of concern, but poor implementation of preventive measures as well.5,6 Prevention should be delivered (i) at the general population level by promoting healthy lifestyle behaviour7 and (ii) at the individual level, i.e. in those subjects at moderate to high risk of CVD or patients with established CVD, by tackling unhealthy lifestyles (e.g. poor-quality diet, physical inactivity, smoking) and by optimising risk factors. Prevention is effective: the elimination of health risk behaviours would make it possible to prevent at least 80% of CVDs and even 40% of cancers.
Key Findings
1
Recommendations are based on the evidence available when the guidelines were developed.
2
The abstract does not report specific clinical outcomes, comparative results, or quantitative performance measures.
3
The document presents the 2016 European Society of Cardiology guidelines for cardiovascular disease prevention in clinical practice.
4
The guidelines reflect the European Society of Cardiology’s considered interpretation of scientific and medical knowledge available at publication.
Research Object
European clinical practice guidelines for cardiovascular disease prevention
Research Subject
clinical practice recommendations for cardiovascular disease prevention based on available scientific evidence
Publication Details
Publication Date
2016-05-23
Journal
Publisher
ISSN
Cited by
6731
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai20
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults2011
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)2012
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes2008
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 20122012
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines2004
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats2015
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes2015
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet2013
European guidelines on cardiovascular disease prevention in clinical practice: executive summary2007
ESC/EAS Guidelines for the management of dyslipidaemias2011
Forecasting the Future of Cardiovascular Disease in the United States2011
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes2014
Nicotine replacement therapy for smoking cessation2012
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2013
Exercise-based cardiac rehabilitation for coronary heart disease2011
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries2015
Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults2010
Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation2010
Cited by20
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
2018 ESC/ESH Guidelines for the management of arterial hypertension2018
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2020
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk2019
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2019
2020 International Society of Hypertension Global Hypertension Practice Guidelines2020
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death2022
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)2017
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension2023
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2022
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease2020
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology2020
Action Plan for Stroke in Europe 2018–20302018
Arterial hypertension in adults. Clinical guidelines 20202020
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes2020
2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines2022
Primary Prevention With Statins in the Elderly2018
Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning2020